Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jennifer G. Chickering"'
Autor:
Daniel P. Zimmer, Courtney M. Shea, Jenny V. Tobin, Boris Tchernychev, Peter Germano, Kristie Sykes, Ali R. Banijamali, Sarah Jacobson, Sylvie G. Bernier, Renee Sarno, Andrew Carvalho, Yueh-tyng Chien, Regina Graul, Emmanuel S. Buys, Juli E. Jones, James D. Wakefield, Gavrielle M. Price, Jennifer G. Chickering, G. Todd Milne, Mark G. Currie, Jaime L. Masferrer
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic 3',5' GMP (cGMP) signaling plays a central role in regulation of diverse processes including smooth muscle relaxation, inflammation, and fibrosis. sGC is activated by the short-lived physiologi
Externí odkaz:
https://doaj.org/article/e994be112c3a40db87031271143e9556
Autor:
George Bakris, Albert T. Profy, Jennifer G. Chickering, Jelena P. Seferovic, John P. Hanrahan, Ian H. de Boer, Michael D. Cressman, Mark G. Currie, James Wakefield, G. Todd Milne, Kenneth E. Carlson, Phebe J. Wilson, Yueh-Tyng Chien
Publikováno v:
Clin J Am Soc Nephrol
Background and objectives Impaired nitric oxide signaling through soluble guanylate cyclase has been implicated in the pathophysiology of diabetic kidney disease. Praliciguat, a soluble guanylate cyclase stimulator that amplifies nitric oxide signali
Autor:
Sarah Jacobson, Jenny Tobin, Renee Sarno, Jaime L. Masferrer, Andrew Carvalho, Boris Tchernychev, Yueh-Tyng Chien, G. Todd Milne, Jennifer G. Chickering, Peter Germano, Ali R. Banijamali, Gavrielle M Price, Emmanuel S. Buys, James Wakefield, Regina Graul, Juli E. Jones, Courtney Shea, Sylvie G. Bernier, Daniel P. Zimmer, Kristie Sykes, Mark G. Currie
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic 3',5' GMP (cGMP) signaling plays a central role in regulation of diverse processes including smooth muscle relaxation, inflammation, and fibrosis. sGC is activated by the short-lived physiologi
Autor:
Regina Graul, Jennifer G. Chickering, Daniel P. Zimmer, Yueh-Tyng Chien, George Todd Milne, Jaime L. Masferrer, John R. Hadcock, Emmanuel S. Buys, Albert T. Profy
Publikováno v:
Nitric Oxide. 78:72-80
Nitric oxide (NO)-sensitive soluble guanylyl cyclase (sGC), an enzyme that catalyzes the conversion of guanosine-5'-triphosphate (GTP) to cyclic guanosine-3',5'-monophophate (cGMP), transduces many of the physiological effects of the gasotransmitter
Autor:
Linda Morrow, Daniel P. Zimmer, Jennifer G. Chickering, Jelena P. Seferovic, Andrew L. Frelinger, Kenneth E. Carlson, Phebe J. Wilson, Mark G. Currie, G. Todd Milne, James Wakefield, Joon Jung, Albert T. Profy, John P. Hanrahan, Michael Hall, Alan D. Michelson
Publikováno v:
Diabetologia
Aims/hypothesis Praliciguat (IW-1973), a soluble guanylate cyclase stimulator, amplifies nitric oxide signalling. This exploratory trial investigated the safety, tolerability, pharmacokinetic profile and pharmacodynamic effects of praliciguat in indi
Autor:
Michael Hall, Albert T. Profy, Jennifer G. Chickering, Marina Mihova, James Wakefield, G. Todd Milne, Mark G. Currie, John P. Hanrahan, Dennis Ruff, Phebe J. Wilson, Daniel P. Zimmer
Publikováno v:
Diabetes. 67
Background: Impaired nitric oxide (NO) signaling through soluble guanylate cyclase (sGC) has been associated with microvascular complications of diabetes. Praliciguat (IW-1973), an sGC stimulator that enhances NO signaling, reduced fasting plasma glu
Autor:
Albert T. Profy, G. Todd Milne, Marina Mihova, Michael Hall, Dennis Ruff, James Wakefield, Phebe J. Wilson, Mark G. Currie, Jennifer G. Chickering, John P. Hanrahan
Publikováno v:
Clinical pharmacology in drug development. 8(5)
Nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signaling is central to the regulation of several physiological processes, including blood flow and inflammation. Deficient NO signaling is implicated in multiple
Autor:
Anthony Lembo, Bernard J. Lavins, S J Shiff, M Currie, Jeffrey M. Johnston, Jennifer G. Chickering, Xinming Hao, X. D. Jia, Caroline B. Kurtz, Lin Chang
Publikováno v:
Alimentary Pharmacology & Therapeutics
Background Few clinical trials in chronic idiopathic constipation (CIC) patients have evaluated abdominal symptom severity and whether CIC patients with abdominal symptoms respond similarly to patients with limited abdominal symptoms. Aims To examine
Autor:
Correia, Susana S.1 (AUTHOR), Liu, Guang1 (AUTHOR), Jacobson, Sarah1 (AUTHOR), Bernier, Sylvie G.1 (AUTHOR), Tobin, Jenny V.1 (AUTHOR), Schwartzkopf, Chad D.1 (AUTHOR), Atwater, Emily1 (AUTHOR), Lonie, Elisabeth2 (AUTHOR), Rivers, Sam1 (AUTHOR), Carvalho, Andrew1 (AUTHOR), Germano, Peter1 (AUTHOR), Tang, Kim2 (AUTHOR), Iyengar, Rajesh R.1 (AUTHOR), Currie, Mark G.1 (AUTHOR), Hadcock, John R.1 (AUTHOR), Winrow, Christopher J.1 (AUTHOR), Jones, Juli E.1 (AUTHOR) jjones@cyclerion.com
Publikováno v:
Journal of Neuroinflammation. 9/18/2021, Vol. 18 Issue 1, p1-13. 13p.
Autor:
Tchernychev, Boris1 (AUTHOR), Li, Huihui2 (AUTHOR), Lee, Sung‐Kyun2 (AUTHOR), Gao, Xin2 (AUTHOR), Ramanarasimhaiah, Raghunath1 (AUTHOR), Liu, Guang1 (AUTHOR), Hall, Katherine C.1 (AUTHOR), Bernier, Sylvie G.1 (AUTHOR), Jones, Juli E.1 (AUTHOR), Feil, Susanne3 (AUTHOR), Feil, Robert3 (AUTHOR), Buys, Emmanuel S.1 (AUTHOR) ebuys@cyclerion.com, Graul, Regina M.1 (AUTHOR), Frenette, Paul S.2 (AUTHOR), Masferrer, Jaime L.1 (AUTHOR)
Publikováno v:
British Journal of Pharmacology. Sep2021, Vol. 178 Issue 17, p3463-3475. 13p. 10 Graphs.